Japan Histology And Cytology Market Size & Outlook
Related Markets
Japan histology and cytology market highlights
- The Japan histology and cytology market generated a revenue of USD 1,407.0 million in 2024 and is expected to reach USD 3,373.5 million by 2030.
- The Japan market is expected to grow at a CAGR of 15.7% from 2025 to 2030.
- In terms of segment, cytology was the largest revenue generating type in 2024.
- Cytology is the most lucrative type segment registering the fastest growth during the forecast period.
Histology and cytology market data book summary
| Market revenue in 2024 | USD 1,407.0 million |
| Market revenue in 2030 | USD 3,373.5 million |
| Growth rate | 15.7% (CAGR from 2025 to 2030) |
| Largest segment | Cytology |
| Fastest growing segment | Cytology |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Histology, Cytology |
| Key market players worldwide | Hologic Inc, BD, Abbott Laboratories, Merck KGaA, Roche Holding AG, Thermo Fisher Scientific Inc, Becton Dickinson & Co, Danaher Corp, Sysmex Corp, Koninklijke Philips NV |
Other key industry trends
- In terms of revenue, Japan accounted for 6.7% of the global histology and cytology market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan histology and cytology market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 3,037.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Histology And Cytology Market Scope
Histology And Cytology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | https://www.bd.com |
| Sysmex Corp | View profile | 10448 | 1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, Japan, 6510073 | http://www.sysmex.co.jp |
| Hologic Inc | View profile | 6990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | http://www.hologic.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Koninklijke Philips NV | View profile | 73712 | Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC | https://www.philips.com |
| Becton Dickinson & Co | View profile | 73000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | https://www.bd.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Japan histology and cytology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to histology and cytology market will help companies and investors design strategic landscapes.
Cytology was the largest segment with a revenue share of 72.05% in 2024. Horizon Databook has segmented the Japan histology and cytology market based on histology, cytology covering the revenue growth of each sub-segment from 2018 to 2030.
According to the 2019 publications of Japan HPV Information Centre, cervical cancer has been recognized as the 11th leading cause of death in females in Japan. In 2020, an estimated 4,213 mortalities and 12,785 new cases occurred in the country. High survival rates are proof of a robust and organized healthcare system in Japan.
Cervical screening in Japan takes place at arious instances such as Moreover, presence of high-quality cytology laboratories results in efficient cytology-based screening programs and accurate interpretation of samples. In June 2016, the 19th International Congress of Cytology was held in Yokohama to increase awareness about advancements in cytology. The Japanese Society of Clinical Cytology aims to develop and furnish cytodiagnosis by combining various new technologies from other fields of medical science with cytology to form a screening or diagnostic modality.
In addition, the Japanese Society of Clinical Cytology held its 59th annual spring meeting in June 2018; this meeting was held to discuss the problems faced by clinicians while adopting cytological diagnostic techniques across Japan and their potential solutions. The Japanese population has better longevity among other countries; hence, the geriatric patients are more likely to develop chronic diseases especially cancer. This is likely to drive the market in Japan. Medical & Biological Laboratories Co., Ltd.; Sysmex Corporation; F. Hoffmann-La Roche Ltd.; and Becton, Dickinson & Company are some of the major players in Japan.
Reasons to subscribe to Japan histology and cytology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan histology and cytology market databook
-
Our clientele includes a mix of histology and cytology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan histology and cytology market , including forecasts for subscribers. This country databook contains high-level insights into Japan histology and cytology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan histology and cytology market size, by type, 2018-2030 (US$M)
Japan Histology And Cytology Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
